Latest / Evidence at the Bedside
Clostridioides difficile Infections: 2021 ACG C. Diff Guidelines
Master the 2021 ACG clinical updates for Clostridioides difficile Infection (CDI). We break down the diagnostic challenges of NAAT vs. Toxin assays, the shift toward fidaxomicin as the preferred first-line agent, and the latest evidence for fecal microbiota transplantation (FMT). Essential listening for gastroenterologists, infectious disease specialists, and hospitalists.
#Cdiff #ACG2021 #Gastroenterology #InfectiousDisease #MedEd #ClinicalGuidelines #EvidenceAtTheBedside
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.